Product Description
For Diabetes Mellitus (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01370707)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: HK inno.N
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Type 2 Diabetes
Phase 1: General Diabetes|Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| CJ_VCM_103 | P1 |
Completed |
General Diabetes|Healthy Volunteers |
2010-02-01 |
2020-07-16 |
Primary Endpoints |
|
| CJ_VCM_102 | P1 |
Completed |
General Diabetes|Healthy Volunteers |
2009-11-01 |
2020-07-16 |
Primary Endpoints|Treatments |
|
| CJ_VCM_301 | P3 |
Completed |
Type 2 Diabetes |
2012-07-01 |
2020-07-16 |
Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|